Oncology
Symposium
Molecular footprints in lung cancer diagnosis and management
Translational
Aims : To examine the evidence behind current perceptions of molecular biomarkers, genetics, and genomics in thoracic oncology; to provide an overview of the cutting-edge research in terms of lung cancer treatment.
Target audience :
Allied health professional, Clinician, Epidemiologist, Fellow, General practitioner, Junior member, Nurse, Oncologist, Pathologist, Patient, Public health official, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Scientist, Student, Thoracic endoscopist, Thoracic surgeon, Trainee
Chairs
T. Sethi
Haddington (East Lothian)
(United Kingdom)
10:45
Molecular predictors of disease progression: have we made any progress?
T. Blum(Berlin, Germany)
COI
-
Description
1
1947
11:15
Discovery of new drugs in thoracic oncology
A. Dingemans(Maastricht, Netherlands)
COI
-
Description
2
1948
11:45
Lung cancer: what are the genetic and genomic perspectives?
K. Fong(Chermside (QLD), Australia)
COI
-
Description
3
1949
12:15
Stem cells and lung cancer treatment: any hope?
S. Janes(London, United Kingdom)
COI
-
Description
4
1950
. . .